These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12440603)

  • 41. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term clinical outcomes following elective stent implantation for unprotected left main coronary artery disease.
    Hu WS; Lee SH; Chiu CZ; Shyu KG; Lin SC; Hung HF; Liou JY; Cheng JJ
    J Formos Med Assoc; 2011 Jan; 110(1):19-26. PubMed ID: 21316009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Aged Patients With Unprotected Left Main Artery Lesions.
    Wei Z; Xie J; Wang K; Kang L; Dai Q; Bai J; Xu B
    Int Heart J; 2016 Dec; 57(6):682-688. PubMed ID: 27829638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME).
    Morrison DA; Sethi G; Sacks J; Henderson W; Grover F; Sedlis S; Esposito R; Ramanathan K; Weiman D; Saucedo J; Antakli T; Paramesh V; Pett S; Vernon S; Birjiniuk V; Welt F; Krucoff M; Wolfe W; Lucke JC; Mediratta S; Booth D; Barbiere C; Lewis D;
    J Am Coll Cardiol; 2001 Jul; 38(1):143-9. PubMed ID: 11451264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
    van Domburg RT; Daemen J; Morice MC; de Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; van Es GA; Wittebols K; Macours N; Stoll HP; Serruys PW
    EuroIntervention; 2010 Apr; 5(8):962-7. PubMed ID: 20542782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Hayano M; Furukawa Y; Nakagawa Y; Tazaki J; Imai M; Yamaji K; Tada T; Natsuaki M; Saijo S; Funakoshi S; Nagao K; Hanazawa K; Ehara N; Kadota K; Iwabuchi M; Shizuta S; Abe M; Sakata R; Okabayashi H; Hanyu M; Yamazaki F; Shimamoto M; Nishiwaki N; Imoto Y; Komiya T; Horie M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2012 Oct; 110(7):924-32. PubMed ID: 22721575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry.
    Holubkov R; Laskey WK; Haviland A; Slater JC; Bourassa MG; Vlachos HA; Cohen HA; Williams DO; Kelsey SF; Detre KM;
    Am Heart J; 2002 Nov; 144(5):826-33. PubMed ID: 12422151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial.
    Vieira RD; Hueb W; Hlatky M; Favarato D; Rezende PC; Garzillo CL; Lima EG; Soares PR; Hueb AC; Pereira AC; Ramires JA; Kalil Filho R
    Circulation; 2012 Sep; 126(11 Suppl 1):S145-50. PubMed ID: 22965975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 56. Restenosis in the coronary stent is an argument for the surgical myocardial revascularization.
    Goleanu V; Tintoiu I; Iacob M; Pinte F; Gafencu M; Mocanu I; Mustaţă D; Droc I; Dumitraşcu G; Greere V; Neagoe G; Lazar O; Labont B; Teodorescu A; Ravescu M; Trandafir D
    Rom J Intern Med; 2003; 41(3):227-35. PubMed ID: 15526506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of sirolimus-eluting stent restenosis: additional stent, balloon angioplasty, and coronary artery bypass graft.
    Ishikawa K; Aoyama Y; Kato K; Tanaka A; Hiramatsu M; Ajioka M; Kamiya H; Tanaka T; Hirayama H
    J Card Surg; 2013 Mar; 28(2):97-101. PubMed ID: 23347085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HRQoL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina.
    Loponen P; Luther M; Korpilahti K; Wistbacka JO; Huhtala H; Laurikka J; Tarkka MR
    Scand Cardiovasc J; 2009 Apr; 43(2):94-9. PubMed ID: 18819033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.